Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Nov;32(11):1213-1225.
doi: 10.1007/s10552-021-01467-5. Epub 2021 Jun 27.

A sequential explanatory study of the employment experiences of population-based breast, colorectal, and prostate cancer survivors

Affiliations

A sequential explanatory study of the employment experiences of population-based breast, colorectal, and prostate cancer survivors

Shoshana Adler Jaffe et al. Cancer Causes Control. 2021 Nov.

Abstract

Purpose: Cancer treatment often leads to work disruptions including loss of income, resulting in long-term financial instability for cancer survivors and their informal caregivers.

Methods: In this sequential explanatory study, we conducted a cross-sectional survey of employment experiences among ethnically diverse, working-age individuals diagnosed with breast, colorectal, or prostate cancer. Following the survey, we conducted semi-structured interviews with cancer survivors and informal caregivers to explore changes in employment status and coping techniques to manage these changes.

Results: Among employed survivors (n = 333), cancer caused numerous work disruptions including issues with physical tasks (53.8%), mental tasks (46.5%) and productivity (76.0%) in the workplace. Prostate cancer survivors reported fewer work disruptions than female breast and male and female colorectal cancer survivors. Paid time off and flexible work schedules were work accommodations reported by 52.6% and 36.3% of survivors, respectively. In an adjusted regression analysis, household income was positively associated with having received a work accommodation. From the qualitative component of the study (survivors n = 17; caregivers n = 11), three key themes emerged: work disruptions, work accommodations, and coping mechanisms to address the disruptions. Survivors and caregivers shared concerns about lack of support at work and resources to navigate issues caused by changes in employment.

Conclusions: This study characterized employment changes among a diverse group of cancer survivors. Work accommodations were identified as a specific unmet need, particularly among low-income cancer survivors. Addressing changes in employment among specific groups of cancer survivors and caregivers is critical to mitigate potential long-term consequences of cancer.

Keywords: Cancer; Caregivers; Employment; Mixed-methods; Survivors.

PubMed Disclaimer

Conflict of interest statement

Conflicts of interest: The authors declare that they have no conflict of interest.

Figures

Fig 1
Fig 1
Consort Diagram

References

    1. National Cancer Institute: Age and Cancer Risk. (2015) https://www.cancer.gov/about-cancer/causes-prevention/risk/age). Accessed20 Sep 2019
    1. Yabroff KR, Warren JL, Knopf K, et al. (2005) Estimating patient time costs associated with colorectal cancer care. Med Care 43:640–648. 10.1097/01.mlr.0000167177.45020.4a - DOI - PubMed
    1. Spelten ER, Verbeek JHAM, Uitterhoeve ALJ, et al. (2003) Cancer, fatigue and the return of patients to work - A prospective cohort study. Eur J Cancer 39:1562–1567. 10.1016/S0959-8049(03)00364-2 - DOI - PubMed
    1. Yabroff KR, Dowling EC, Guy Gery P J, et al. (2016) Financial Hardship Associated With Cancer in the United States: Findings From a Population-Based Sample of Adult Cancer Survivors. J Clin Oncol 34:259–267. 10.1200/JCO.2015.62.0468 - DOI - PMC - PubMed
    1. McDougall JA, Banegas MP, Wiggins CL, et al. (2018) Rural Disparities in Treatment-Related Financial Hardship and Adherence to Surveillance Colonoscopy in Diverse Colorectal Cancer Survivors. Cancer Epidemiol Biomarkers Prev 27:1275–1282. 10.1158/1055-9965.EPI-17-1083 - DOI - PMC - PubMed